43 related articles for article (PubMed ID: 31906779)
1. VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report.
Gunaratnam C; Muzicenco O; Sivagurunathan P; Franzco MH
J Surg Case Rep; 2024 Mar; 2024(3):rjae104. PubMed ID: 38455982
[TBL] [Abstract][Full Text] [Related]
2. INTRAVITREAL METHOTREXATE IN VEMURAFENIB-INDUCED UVEITIS.
Dugauquier A; Awada AH; Motulsky E; Kisma N
Retin Cases Brief Rep; 2024 Jul; 18(4):455-458. PubMed ID: 36977328
[TBL] [Abstract][Full Text] [Related]
3. INDOCYANINE GREEN ANGIOGRAPHY-GUIDED PHOTOCOAGULATION OF LARGE MICROVASCULAR ABNORMALITIES ("TELCAPS") IN A PATIENT WITH PERSISTENT MACULA EDEMA IN THE CONTEXT OF RADIATION RETINOPATHY.
Perrin EL; Porter RGB
Retin Cases Brief Rep; 2024 May; 18(3):355-359. PubMed ID: 36512805
[TBL] [Abstract][Full Text] [Related]
4. Retraction of cystoid macular edema from the fovea after intravitreal anti-VEGF therapy for birdshot chorioretinopathy.
Ba-Ali S; Fuchs J; Larsen M
Retin Cases Brief Rep; 2023 Oct; ():. PubMed ID: 37874763
[TBL] [Abstract][Full Text] [Related]
5. PEMBROLIZUMAB-RELATED BILATERAL OCULAR HYPOTONY ASSOCIATED WITH CILIARY DETACHMENTS AND MACULA OEDEMA: A TREATMENT-RESISTANT SIDE EFFECT.
Bec L; Khouri C; Chiquet C
Retin Cases Brief Rep; 2024 Mar; ():. PubMed ID: 38452261
[TBL] [Abstract][Full Text] [Related]
6. A case report of pediatric-onset MS associated uveitis.
Mahdizad Z; Zarei M; Fakhredin H; Samiee R; Heidari H; Ebrahimiadib N
J Ophthalmic Inflamm Infect; 2024 May; 14(1):21. PubMed ID: 38811495
[TBL] [Abstract][Full Text] [Related]
7. Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment.
Chang MS; Lee SW; Kim S; Lee CS; Byeon SH; Kim SS; Kim YJ
Ophthalmology; 2024 Jul; 131(7):867-869. PubMed ID: 38522600
[No Abstract] [Full Text] [Related]
8. Long-Term Stability of Melanocytomas With Persistent Vascular Activity Without Malignant Transformation.
Bonafonte S; Gold AS; Latiff A; Murray TG
J Vitreoretin Dis; 2024; 8(2):200-202. PubMed ID: 38465356
[No Abstract] [Full Text] [Related]
9. Melanoma Treatment: The Heart Has Skin in the Game.
Mauro AG; Yazbeck V; Salloum FN
JACC CardioOncol; 2022 Nov; 4(4):549-551. PubMed ID: 36444230
[TBL] [Abstract][Full Text] [Related]
10. Ocular side effects of target therapy and immunotherapy in patients with cutaneous malignant melanoma.
Eikenberry J; Harris A; Torabi R; Lang M; Denney D; Verticchio Vercellin A; Siesky B
Eur J Ophthalmol; 2021 May; 31(3):1391-1398. PubMed ID: 32476450
[TBL] [Abstract][Full Text] [Related]
11. [Ocular side effects of modern oncological therapy : Immunological checkpoint and MEK/BRAF signal transduction inhibitors].
Thurau S; Wildner G; Gamulescu MA
Ophthalmologie; 2023 May; 120(5):559-573. PubMed ID: 37160621
[TBL] [Abstract][Full Text] [Related]
12. Chronic Unilateral Uveitis with Macular Edema Secondary to Dabrafenib for Pilocytic Astrocytoma.
Chang M; Kuriakose RK; Xu K; Almeida DRP; Chin EK
Case Rep Ophthalmol; 2021; 12(2):574-577. PubMed ID: 34248594
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma.
Woltsche N; Kruger MA; Weger M; Wolf IH; Seidel G
Ocul Immunol Inflamm; 2021 Jul; 29(5):845-847. PubMed ID: 31906779
[No Abstract] [Full Text] [Related]
14. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Lim J; Lomax AJ; McNeil C; Harrisberg B
Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
[TBL] [Abstract][Full Text] [Related]
15. Choroidal Neovascularization in Multifocal Choroiditis after Dabrafenib and Trametinib.
Albertini GC; Corbelli E; Battaglia Parodi M; Bandello F
Eur J Ophthalmol; 2017 Nov; 27(6):e184-e186. PubMed ID: 28777388
[TBL] [Abstract][Full Text] [Related]
16. Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II).
Atkinson V; Sandhu S; Hospers G; Long GV; Aglietta M; Ferrucci PF; Tulyte S; Cappellini GCA; Soriano V; Ali S; Poprach A; Cesas A; Rodriguez-Abreu D; Lau M; de Jong E; Legenne P; Stein D; King B; van Thienen JV
Melanoma Res; 2020 Jun; 30(3):261-267. PubMed ID: 31895752
[TBL] [Abstract][Full Text] [Related]
17. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
18. Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations.
Spain L; Julve M; Larkin J
Expert Opin Pharmacother; 2016; 17(7):1031-8. PubMed ID: 27027150
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
